9-65283218-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001126334.1(FOXD4L5):āc.1160G>Cā(p.Ser387Thr) variant causes a missense change. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001126334.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 4AN: 96102Hom.: 0 Cov.: 11 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000256 AC: 35AN: 1365348Hom.: 2 Cov.: 27 AF XY: 0.0000235 AC XY: 16AN XY: 680470
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000416 AC: 4AN: 96214Hom.: 0 Cov.: 11 AF XY: 0.0000885 AC XY: 4AN XY: 45190
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1160G>C (p.S387T) alteration is located in exon 1 (coding exon 1) of the FOXD4L5 gene. This alteration results from a G to C substitution at nucleotide position 1160, causing the serine (S) at amino acid position 387 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.